Pricing Log in Create free account

Neumora Therapeutics, Inc. (NMRA) vs Pelthos Therapeutics Inc. (PTHS)

Neumora Therapeutics, Inc. and Pelthos Therapeutics Inc. are both Biotechnology companies. Neumora Therapeutics, Inc. and Pelthos Therapeutics Inc. are of similar size ($80.2M and $77.6M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 13 metrics below, Neumora Therapeutics, Inc. leads on 7 and Pelthos Therapeutics Inc. on 6.

Valuation

Metric NMRA PTHS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.65 9.71
P/B 1.95 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.75 9.21
Earnings yield (261.70%) (142.54%) (33.15%)
Free cash flow yield (207.20%) (59.72%) (25.50%)

Profitability

Metric NMRA PTHS Biotechnology median
Gross margin 0.00% 78.59% 65.16%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity (187.11%) 2,161.07% (56.36%)
Return on assets (121.89%) (125.04%) (48.04%)
Return on invested capital 0.00% (82.34%) 0.00%

Growth

Metric NMRA PTHS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 5.23% (61.12%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric NMRA PTHS Biotechnology median
Debt to equity 1.19 (46.58) 0.00
Current ratio 4.50 1.98 4.72
Net debt to EBITDA 0.53 (0.45) 0.96

Dividend

Metric NMRA PTHS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NMRA PTHS Biotechnology median
Market cap 80.23m 77.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack